BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 2047070)

  • 1. Prognostic factors associated with recurrence in clinical stage I adenocarcinoma of the endometrium.
    Lurain JR; Rice BL; Rademaker AW; Poggensee LE; Schink JC; Miller DS
    Obstet Gynecol; 1991 Jul; 78(1):63-9. PubMed ID: 2047070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study.
    Creasman WT; Morrow CP; Bundy BN; Homesley HD; Graham JE; Heller PB
    Cancer; 1987 Oct; 60(8 Suppl):2035-41. PubMed ID: 3652025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HISTOPATHOLOGIC PARAMETERS OF POSITIVE LYMPH NODE PREDICTABILITY IN ENDOMETRIAL CANCER.
    Mandić A; Kokanov D; Maričić S; Ivković Kapicl T; Šolajić N
    Acta Clin Croat; 2022 Aug; 61(2):206-213. PubMed ID: 36818933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sentinel Lymph Node Mapping in Presumed Low- and Intermediate-Risk Endometrial Cancer Management (SLIM): A Multicenter, Prospective Cohort Study in The Netherlands.
    Burg LC; Kruitwagen RFPM; de Jong A; Bulten J; Bonestroo TJJ; Kraayenbrink AA; Boll D; Lambrechts S; Smedts HPM; Bouman A; Engelen MJA; Kasius JC; Bekkers RLM; Zusterzeel PLM
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Morbid Obesity on the Outcomes of Type II Endometrial Cancer: a Cohort Study.
    Gaballa K; Metwally IH; Refky B; Awny S; Abdelkhalek M; Hamdy M
    Indian J Surg Oncol; 2022 Sep; 13(3):453-458. PubMed ID: 36187516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and Emerging Prognostic Biomarkers in Endometrial Cancer.
    Njoku K; Barr CE; Crosbie EJ
    Front Oncol; 2022; 12():890908. PubMed ID: 35530346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Adjuvant Chemotherapy Necessary in Patients with Early Endometrial Cancer?
    Iida Y; Komatsu H; Okawa M; Osaku D; Nosaka K; Sato S; Oishi T; Taniguchi F; Harada T
    Yonago Acta Med; 2022 Feb; 65(1):82-87. PubMed ID: 35221763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective comparison of the diagnostic accuracies of ultrasound and magnetic resonance imaging in preoperative staging of endometrial cancer.
    Wong M; Amin T; Thanatsis N; Naftalin J; Jurkovic D
    J Gynecol Oncol; 2022 Mar; 33(2):e22. PubMed ID: 35128854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant brachytherapy for FIGO stage I serous or clear cell endometrial cancer.
    Jeans EB; Breen WG; Mullikin TC; Looker BA; Mariani A; Keeney GL; Haddock MG; Petersen IA
    Int J Gynecol Cancer; 2021 Jun; 31(6):859-867. PubMed ID: 33563642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometrial Carcinoma, Grossing and Processing Issues: Recommendations of the International Society of Gynecologic Pathologists.
    Malpica A; Euscher ED; Hecht JL; Ali-Fehmi R; Quick CM; Singh N; Horn LC; Alvarado-Cabrero I; Matias-Guiu X; Hirschowitz L; Duggan M; Ordi J; Parkash V; Mikami Y; Ruhul Quddus M; Zaino R; Staebler A; Zaloudek C; McCluggage WG; Oliva E
    Int J Gynecol Pathol; 2019 Jan; 38 Suppl 1(Iss 1 Suppl 1):S9-S24. PubMed ID: 30550481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative tumor size is associated with deep myometrial invasion and lymph node metastases and is a negative prognostic indicator for patients with endometrial carcinoma.
    Nakamura K; Nakayama K; Ishikawa N; Minamoto T; Ishibashi T; Ohnishi K; Yamashita H; Ono R; Sasamori H; Razia S; Hossain MM; Kamrunnahar S; Ishikawa M; Kyo S
    Oncotarget; 2018 May; 9(33):23164-23172. PubMed ID: 29796179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence.
    Kurnit KC; Kim GN; Fellman BM; Urbauer DL; Mills GB; Zhang W; Broaddus RR
    Mod Pathol; 2017 Jul; 30(7):1032-1041. PubMed ID: 28281553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel model to estimate lymph node metastasis in endometrial cancer patients.
    Anton C; E Silva AS; Baracat EC; Dogan NU; Köhler C; Carvalho JP; di Favero GM
    Clinics (Sao Paulo); 2017 Jan; 72(1):30-35. PubMed ID: 28226030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic role of systematic lymphadenectomy in early-stage endometrial cancer: A systematic review.
    Li MY; Hu XX; Zhong JH; Chen LL; Lin YX
    Oncol Lett; 2016 Jun; 11(6):3849-3857. PubMed ID: 27313706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Accuracy of Integrated [(18)F] Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Detection of Pelvic and Para-aortic Nodal Metastasis in Patients with High Risk Endometrial Cancer.
    Gholkar NS; Saha SC; Prasad G; Bhattacharya A; Srinivasan R; Suri V
    World J Nucl Med; 2014 Sep; 13(3):170-7. PubMed ID: 25538488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel lymph node biopsy in endometrial cancer: description of the technique and preliminary results.
    Kuru O; Topuz S; Sen S; Iyibozkurt C; Berkman S
    J Turk Ger Gynecol Assoc; 2011; 12(4):204-8. PubMed ID: 24591995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body mass index, dose to organs at risk during vaginal brachytherapy, and the role of three-dimensional CT-based treatment planning.
    Boyle JM; Craciunescu O; Steffey B; Cai J; Chino J
    Brachytherapy; 2014; 13(4):332-6. PubMed ID: 24439964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymph node assessment in endometrial cancer: towards personalized medicine.
    Vidal F; Rafii A
    Obstet Gynecol Int; 2013; 2013():892465. PubMed ID: 24191159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pattern of myometrial invasion as a predictor of lymph node metastasis or extrauterine disease in low-grade endometrial carcinoma.
    Euscher E; Fox P; Bassett R; Al-Ghawi H; Ali-Fehmi R; Barbuto D; Djordjevic B; Frauenhoffer E; Kim I; Hong SR; Montiel D; Moschiano E; Roma A; Silva E; Malpica A
    Am J Surg Pathol; 2013 Nov; 37(11):1728-36. PubMed ID: 24061515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of lymph node and lung metastases of endometrial cancer by muscle-mediated expression of soluble vascular endothelial growth factor receptor-3.
    Takahashi K; Mizukami H; Saga Y; Takei Y; Urabe M; Kume A; Machida S; Fujiwara H; Suzuki M; Ozawa K
    Cancer Sci; 2013 Aug; 104(8):1107-11. PubMed ID: 23614535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.